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Amino acid sequences of nucleocapsid proteins are
mostly conserved among different rhabdoviruses. The
protein plays a common functional role in different RNA
viruses by enwrapping the viral genomic RNA in an
RNase-resistant form. Upon expression of the nucleo-
capsid protein alone in COS cells and in bacteria, it
forms large insoluble aggregates. In this work, we have
reported for the first time the full-length cloning of the
N gene of Chandipura virus and its expression in Esch-
erichia coli in a soluble monomeric form and purifica-
tion using nonionic detergents. The biological activity of
the soluble recombinant protein has been tested, and it
was found to possess efficient RNA-binding ability. The
state of aggregation of the recombinant protein was
monitored using light scattering. In the absence of non-
ionic detergents, it formed large aggregates. Aggrega-
tion was significantly reduced in the presence of os-
molytes such as D-sorbitol. Aggregate formation was
suppressed in the presence of another viral product,
phosphoprotein P, in a chaperone-like manner. Both the
osmolyte and phosphoprotein P also suppressed aggre-
gation to a great extent during refolding from a guani-
dine hydrochloride-denatured form. The function of the
phosphoprotein and osmolyte appears to be synergistic
to keep the N-protein in a soluble biologically competent
form in virus-infected cells.
The ()-strand RNA viruses (rhabdovirus, influenza, rabies,
measles, and Ebola) consist of important human pathogens,
including Chandipura virus (CHPV),1 a member of the Rhab-
doviridae family (1). The structure, function, and genetic
makeup of this negative sense RNA virus resemble those of
vesicular stomatitis virus (VSV). Still, it can be distinguished
from two other members of the rhabdovirus family, VSV New
Jersey serotype and VSV Indiana serotype, not only in its host
species origin and serology (2), but also in nucleotide sequences
of genes and amino acid sequences of proteins (3). Upon infec-
tion by members of the rhabdovirus family, five major viral
proteins, N (nucleocapsid), P (phosphoprotein), L (large), M
(matrix), and G (glycoprotein), are synthesized. The N-protein
encapsidates genomic RNA in a precise structure that can be
compared with histone-mediated enwrapping of a DNA mole-
cule into a nucleosome structure. Only this encapsidated form
of the genome can be recognized by viral polymerase as its
template during both transcription and replication (4). Nucle-
ocapsid proteins not only protect the viral genome from RNase
action, but are also thought to play some vital regulatory roles
in the transition from transcription to replication in the viral
life cycle, referred to as the transcription-replication switch.
Previous studies have indicated that the N-protein has a
common tendency to form large aggregates that are biologically
inactive. In VSV, it was observed that interaction of the N-
protein with the P-protein keeps the N-protein in a soluble
form in vivo that is capable of enwrapping the de novo synthe-
sized genomic RNA. N-protein/P-protein interaction also may
confer specificity for RNA-binding activity (5) of the N-protein
where it channels the N-protein pool to viral RNA sequences
only. This regulatory importance of N-protein/P-protein inter-
action makes it an important biological event in the viral life
cycle. In influenza virus, the nucleoprotein was found to inter-
act with viral RNA polymerase, directly modulating its activity
(6). In VSV, it has been proposed that the P-protein in its
phosphorylated multimeric state forms a complex with the
L-protein to produce functional transcriptase, whereas in its
unphosphorylated state, it complexes with the L-protein to
form replicase. The N-protein has been suggested to be an
integral member of the replicase complex (7). The multifunc-
tional nature of the N-protein and its interaction with different
targets make this viral product an attractive model for a de-
tailed structure-function analysis in the CHPV system so that
its precise role in different stages of the viral life cycle can be
elucidated.
One of the important aspects of N-protein function is the
maintenance of its active and soluble form. As mentioned be-
fore, in its free form, the protein has a tendency to form aggre-
gates in vitro and perhaps in vivo (8). How the cellular envi-
ronment maintains a soluble and active pool of the N-protein is
crucial to understanding the roles played by various cellular
factors in the viral life cycle. Clearly, the P-protein increases
the solubility of the N-protein in vivo through formation of
complexes. However, the structural nature of the N-protein in
these complexes is not known. Thus, the possibility is raised
that the P-protein may be interacting with a disordered N-
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protein in a chaperone-like fashion. Protein folding studies in
vivo have elucidated the crucial roles of osmolytes (9) and
chaperone systems in suppressing aggregation and shifting the
distribution toward the folded state, thereby enhancing the
activity and solubility of the proteins. A central point in this
study is to understand the roles of the P-protein and intracel-
lular osmolytes in maintaining and enhancing the solubility of
the N-protein, thereby ensuring a steady supply for encapsida-
tion of progeny viruses.
EXPERIMENTAL PROCEDURES
Materials—Pfu DNA polymerase and T4 DNA ligase were from New
England Biolabs (Beverly, MA). Tripure reagentTM and Superscript II
reverse transcriptase were from Life Technologies, Inc. Klenow polym-
erase, SP6 RNA polymerase, DNase, 4-nitro blue tetrazolium chloride,
and 5-bromo-4-chloro-3-indolyl phosphate were from Roche Molecular
Biochemicals. The gel extraction kit was from QIAGEN Inc. The
Mono-Q column was from Amersham Pharmacia Biotech (Uppsala,
Sweden). Alkaline phosphatase-conjugated goat anti-mouse IgG was
from Sigma. I-EDANS was from Molecular Probes, Inc. (Eugene, OR).
Prestained molecular mass markers and Bio-Beads SM-2 adsorbent
were from Bio-Rad. Other common reagents were of analytical grade.
Construction of the Full-length Clone of the N Gene of CHPV by
Isolation of RNA—The viral genomic RNA was isolated from CHPV
(strain 1653514) using Tripure reagentTM according to the manufactur-
er’s protocol. Isolated RNA was estimated qualitatively and quantita-
tively by running 1% MOPS gel and by spectrophotometric analysis at
260 and 280 nm, respectively.
Reverse Transcription-PCR to Amplify the N Gene of CHPV—Two
terminal primers (DJC1 and DJC2) were designed to clone the N gene
by reverse transcription-PCR. Primer DJC1 (5-TTTATA CATATG
AGTTCTCAAGTA-3) included a hexameric anchor followed by an NdeI
restriction enzyme site. The rest of the sequence corresponds to the 5
terminus of the N gene. In primer DJC2 (5-TTTATA GGATCC TCAT-
GCAAAGAG-3), the hexameric anchor was followed by a BamHI re-
striction enzyme site, and the rest of the sequence was complementary
to the 3-end of the N gene (3). First-strand cDNA synthesis was carried
out with primer DJC1 and viral genomic RNA as template using Su-
perscript II reverse transcriptase, and PCR was done with Pfu polym-
erase according to the instructions given by the manufacturer. The PCR
product was run on a 1% agarose gel in 0.5 Tris borate/EDTA (Fig. 1).
Cloning of the N Gene in the pUC18 Vector—The PCR product puri-
fied from the 1% agarose gel using QIAGEN gel extraction resin was
blunt-ended with Klenow polymerase and cloned into SmaI-digested
pUC18 vector using T4 DNA ligase. The ligation mixture was trans-
formed into Escherichia coli XL1-Blue, and positive clones were con-
firmed by restriction digestion, followed by direct sequencing of the
recombinant DNA (Fig. 1).
Subcloning of the N Gene in the pET-3a Vector—The full-length N
gene of CHPV was digested in the pUC18-NC clone with NdeI and
BamHI restriction enzymes, and the released DNA fragment was sub-
cloned into NdeI/BamHI-cut pET-3a vector under the control of the T7
promoter. The recombinant DNA was digested with different restriction
enzymes for further confirmation (Fig. 1).
Expression of the N gene in E. coli—Competent E. coli BL21(DE3)
cells were transformed with pET-3a-NC plasmid DNA, and trans-
formed cells were inoculated in 100 ml of Luria broth supplemented
with 20 mM glucose containing 100 mg/ml ampicillin and incubated at
37 °C under shaking conditions until A600  0.3. Cells were then in-
duced with 500 M IPTG for 4 h at 37 °C (10). After harvesting, the cell
pellet was suspended in 2 ml of buffer A containing 50 mM Tris-HCl, 1
mM EDTA, and 0.1% Triton X-100. For lysis, lysozyme was added at a
concentration of 250 g/ml to buffer A, and the suspension was kept on
ice for 1 h. The cells were then sonicated to reduce the viscosity due to
chromosomal DNA, and lysates were clarified by spinning at 13,000
rpm for 30 min at 4 °C. The soluble supernatant was separated from the
inclusion body pellet. The inclusion body pellet obtained after centrif-
ugation was denatured and taken into 2 ml of a solution of 8 M urea in
buffer A. The soluble and urea fractions were analyzed by 10% SDS-
polyacrylamide gel electrophoresis, followed by Coomassie Blue stain-
ing. Different parameters such as IPTG concentration, temperature,
and duration of induction were varied to maximize expression of the
N-protein in soluble form.
Purification of the Bacterially Expressed N-protein—The N-protein
expressed in soluble form was purified from bacterial lysate through a
Mono-Q anion-exchange fast protein liquid chromatography column.
The column was pre-equilibrated with buffer A containing 200 mM
NaCl, and proteins were eluted with a gradient of NaCl from 200 to 700
mM in a total volume of 25 ml of buffer A. The flow rate and fraction size
were 0.25 ml/min and 1 ml, respectively. Fractions were analyzed on
10% discontinuous SDS-polyacrylamide gel (acrylamide/bisacrylamide
ratio of 30:0.8), followed by Coomassie Blue staining to test the homo-
geneity of the purified protein. The purified N-protein was stored in
buffer A containing 200 mM NaCl and 10% glycerol at 20 °C
Western Blot Analysis—Proteins were subjected to 10% SDS-poly-
acrylamide gel electrophoresis, and Western blotting was performed
with mouse polyclonal anti-CHPV antibody as the primary antibody
and alkaline phosphatase-conjugated goat anti-mouse IgG as the sec-
ondary antibody. This was followed by color reaction with 4-nitro blue
tetrazolium chloride and 5-bromo-4-chloro-3-indolyl phosphate.
Synthesis of 32P-Labeled Leader RNA—A 49-nucleotide leader RNA
gene of CHVP was cloned under the control of the SP6 promoter in the
pGEM-4Z vector. DNA template was linearized with the HindIII re-
striction enzyme. Radiolabeled positive sense leader RNA was synthe-
sized in vitro in a 40-ml reaction with [-32P]UTP and SP6 RNA polym-
erase essentially as described by the manufacturer. DNA template was
removed by RQ1 DNase treatment, and the leader RNA was extracted
with phenol/chloroform and precipitated twice with ethanol. The prod-
uct was analyzed on 10% polyacrylamide gel (29:1) containing 8 M urea
in 1 TAE (40 mM Tris-acetate, 2 mM EDTA, pH 8.0).
In Vitro Encapsidation of Leader RNA—To study the encapsidation
FIG. 1. Cloning of the N gene. Step A,
isolation of viral RNA; step B, first-strand
cDNA synthesis with the DJC1 oligonu-
cleotide using Superscript II reverse tran-
scriptase; step C, PCR of cDNA with prim-
ers DJC1 and DJC2, followed by blunt-
ending of the PCR product with Klenow
polymerase in the absence of dNTPs; step
D, cloning of the reverse transcription-
PCR product into SmaI-digested pUC18
vector; step E, restriction digestion of
pUC18-NC with NdeI and BamHI and
isolation of the N gene-containing frag-
ment; step F, subcloning of the N gene
into the pET-3a vector digested with NdeI
and BamHI under control of the T7 pro-
moter (pT7). tT7, T7 terminator; rbs, ri-
bosome-binding site. The solid bar repre-
sents the N gene open reading frame.
Chaperon-like Action of P-protein 30949
 by guest, on O
ctober 6, 2010
w
w
w
.jbc.org
D
ow
nloaded from
 
reaction, 32P-labeled leader RNA (200 ng) was incubated with increas-
ing amounts of N-protein (0.3–4.5 M). The binding reaction was car-
ried out in a total volume of 15 ml in 10 mM Tris-HCl containing 100 mM
NaCl, 40 mM KCl, 5 mM MgCl2, 1 mM dithiothreitol, and 5% glycerol at
37 °C for 30 min. In the presence and absence of UV cross-linking
(Appligene UV crosslinker), the RNA-protein complex was treated with
RNase A at a final concentration of 60 mg/ml for 15 min. The reaction
was stopped by the addition of 10 loading dye containing 30% Ficoll,
1 mM EDTA, 0.25% bromphenol blue, and 0.25% xylene cyanol. The
reaction mixture was run on a 6% nondenaturing polyacrylamide gel
containing 5% glycerol at 4 °C in TAE (40 mM Tris-acetate, 2 mM EDTA,
pH 8.0) (acrylamide/bisacrylamide of 30:0.8). The gel was dried and
exposed to x-ray film at 70 °C.
Expression and Purification of the Recombinant P-protein from Bac-
teria—The P-protein of CHPV was expressed in bacteria, and only the
soluble fraction was purified as described earlier (11).
Determination of Sulfhydryl Content by DTNB Titration—To deter-
mine the number of reactive sulfhydryl groups by DTNB titration, 10
M CHPV N-protein was incubated with 0.5 mM DTNB in 50 mM
Tris-HCl (pH 8) at 25 °C. The reaction was monitored at 412 nm in a
Hitachi UV-2000 spectrophotometer after an appropriate base-line cor-
rection. A molar extinction coefficient of 1.36  104 M1 cm1 was used
to calculate the number of reactive sulfhydryl groups.
Labeling of the CHPV N-protein with I-EDANS—The purified CHPV
N-protein (10 M) was reacted with 5 mM I-EDANS at 37 °C for 2 h.
After incubation, the protein was dialyzed against 50 mM Tris-HCl (pH
8) containing 150 mM NaCl to remove the unreacted I-EDANS. The
absorbance at 337 nm was measured to check the incorporation of
I-EDANS into the protein with the buffer from the previous dialysis
being used for the base line.
Circular Dichroism Spectroscopy—Circular dichroism spectra were
measured in a Jasco J-700 spectropolarimeter. Measurements were
carried out in 50 mM Tris-HCl (pH 8) containing 150 mM NaCl at
ambient temperature. An average of four scans was taken. A time
constant of 2 s and a scan speed of 50 nm/min were used for spectral
scanning. The protein concentration was 10 M. Proper base-line cor-
rections were made.
Measurement of Steady-state Fluorescence Anisotropy—Anisotropy
experiments were performed using a Hitachi polarization accessory.
The fluorescence intensity components Ivv, Ivh, Ihv, and Ihh (where the
subscripts refer to the horizontal (h) and vertical (v) positioning of the
excitation and emission polarizers, respectively) were used to calculate
the steady-state fluorescence anisotropy (A) according to the following
equation: A  (Ivv  GIvh)/(Ivv  2GIvh), where G is the grating factor
that corrects for the wavelength-dependent distortions of the polarizing
system.
Fluorescence Spectroscopy—Steady-state fluorescence spectra were
recorded in a Hitachi F-3010 spectrofluorometer with spectrum addi-
tion and subtraction facility. The fluorescence experiments were carried
out at 37 °C, and the temperature was maintained by a circulating
water bath attached to the spectrofluorometer. The excitation and emis-
sion band passes were maintained at 5 nm, and all readings were taken
in a cuvette with a 1-cm path length.
Static Light Scattering—Light scattering experiments were done to
check the state of aggregation of the soluble CHPV N-protein and to
monitor the roles of osmolytes and the CHPV P-protein in this aggre-
gation process. The CHPV N-protein at a high concentration was first
treated with Bio-Beads SM-2 adsorbent to remove Triton X-100, filtered
three times through a Millipore filter, and added to a Millipore filtered
buffer under suitable dust-free conditions to a final protein concentra-
tion of 50 M. All additions were made in the cuvette, and light scat-
tering was measured with excitation and emission wavelengths set at
340 nm. To determine the effect of osmolytes, the same experiment was
carried out, but a 250 mM concentration of the osmolyte D-sorbitol was
added during detergent removal from a high concentration of CHPV
N-protein. To determine the effect of the CHPV P-protein on aggrega-
tion, the concentrated stock of detergent-removed CHPV N-protein was
denatured with 8 M urea. The denatured protein was diluted in a native
buffer in the fluorometer cuvette, and scattering intensities were mon-
itored in the presence of varying concentrations of CHPV P-protein and
osmolytes.
Dynamic Light Scattering—Dynamic light scattering experiments
were performed using an Otsuka Electronics DLS700 instrument. For
DLS experiments, the concentration of CHPV N-protein was kept at 1
mg/ml, and the concentration of D-sorbitol was kept at 250 mM. In this
experiment, the sample was illuminated with a 638.8 helium-neon
solid-state laser, and the intensity of light scattered at an angle of 90°
was measured. An auto-correlation function was used to determine the
translational diffusion coefficient (DT) of the sample particles in the
solution by measuring the fluctuations in the intensity of the scattered
light. The hydrodynamic radius (RH) of the sample particles was de-
rived from DT using Stokes-Einstein’s equation: DT  kBT/6RH,
where kB is the Boltzmann constant, T is the absolute temperature in
degrees Kelvin, and  is the solvent viscosity.
RESULTS
To understand the conformation of the N-protein and its role
in the aggregation process, we felt the need to isolate the
soluble N-protein, but not a refolded, which may differ in con-
formation. We observed that when overproduced in bacteria by
inducing cells with 500 M IPTG at 37 °C for 4 h, the N-protein
composed more than 50% of the total cellular proteins. How-
ever, the majority of the overexpressed protein formed inclu-
sion bodies, posing a problem for its purification (data not
shown). We observed that BL21(DE3) cells induced at A600 
0.3 with 100 M IPTG for 14 h at 16 °C produced the majority
of the N-protein in a soluble form. To maximize the amount of
N-protein in a soluble form during purification, we introduced
200 mM NaCl in buffer A and washed the inclusion pellet
FIG. 2. Expression and purification of the recombinant N-pro-
tein in E. coli. Lanes 1 and 2, total protein from cells transformed with
pET-3a and uninduced or induced with IPTG, respectively; lanes 3 and
4, BL21(DE3) cells (pET-3a-NC) uninduced and induced with IPTG,
respectively; lane 5, soluble supernatant fraction from IPTG-induced
cells; lane 6, inclusion bodies extracted with 8 M urea from IPTG-
induced cells; lane 7, N-protein purified through a Mono-Q column (fast
protein liquid chromatography). A, Coomassie Blue-stained 10% SDS-
polyacrylamide gel showing the expression and different stages of pu-
rification of the recombinant N-protein. Protein molecular mass mark-
ers are indicated. B, Western blot analysis of the recombinant protein.
Lane M corresponds to prestained protein molecular mass markers.
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several times with the same buffer. We found that the above
protocol successfully produces 80% of the overexpressed pro-
tein in soluble form (Fig. 2, A and B, lane 5). Western blotting
was performed to further verify the above results (Fig. 2B).
Biological Activity of the Recombinant N-protein—The major
biological role of the nucleocapsid protein is to bind with the
viral genome and to encapsidate it in an RNase-resistant form.
We tested the affinity of the recombinant protein for viral
leader RNA sequence corresponding to the 5-end of the viral
anti-genome by gel electrophoretic mobility shift assays. In
vitro transcribed leader RNA was incubated with increasing
amounts of recombinant N-protein, and the complex was re-
solved on 6% native polyacrylamide (see “Experimental Proce-
dures”). We observed the appearance of a shifted band upon the
addition of protein, and the intensity of the shifted band in-
creased sharply with increasing protein concentrations, indi-
cating a high affinity of the recombinant protein for leader
RNA (Fig. 3A, first through ninth lanes). We next examined the
ability of the recombinant protein to protect viral RNA from
RNase action in vitro. To demonstrate that we have treated the
complex formed between leader RNA and the N-protein with
RNase in another set, the complex was UV-cross-linked and
treated with RNase (Fig. 3A, tenth and eleventh lanes). The
intensity of the shifted band remained the same as that of the
RNase-untreated complex (Fig. 3A, ninth lane), indicating a
true encapsidation of viral leader RNA by the N-protein.
Spectroscopic Studies of the N-protein Structure—CD spectra
have been widely used as to monitor secondary structure. Fig.
4 shows the far-UV CD spectrum of the solubilized N-protein
after removal of Triton X-100. An attempt was made to extract
relative amounts of secondary structure present in the protein
from the CD spectra. Although the quality of fit was not excel-
lent, it indicated a large amount of random-coil form present.
From the work of Baskakov and Bolen (9), it is clear that
physiological concentrations of osmolytes can drive the folding
equilibrium toward the native state. If the random-coil confor-
mations present in the soluble N-protein reflect partial dena-
turation, a significant secondary structure alteration of the
N-protein is anticipated upon addition of an osmolyte. So,
far-UV CD spectra were measured in the presence of an os-
molyte (D-sorbitol), and secondary structure formation was
monitored. The addition of D-sorbitol led to some enhancement
of the CD spectrum and hence secondary structure contents.
We also attempted to measure the effect of osmolytes on
N-protein structure by the use of steady-state fluorescence
anisotropy. Fluorescence anisotropy is a function of probe mo-
tion. In the absence of internal probe motions, fluorescence
FIG. 4. Circular dichroism spectra of the N-protein in the ab-
sence (OO) and presence (– – –) of 250 mM D-sorbitol. Measure-
ments were carried out in 50 mM Tris-HCl (pH 8) containing 150 mM
NaCl at ambient temperature. For each measurement, an average of
four scans was taken. A time constant of 2 s and a scan speed of 50
nm/min were used for spectral scanning. The protein concentration was
10 M. The path length was 1 mm. Each spectrum is an average of four
independent measurements and was smoothed. Error bars at two ends
of the spectra indicate uncertainties. mdeg, millidegrees.
FIG. 3. A, 32P-labeled leader RNA was
incubated with the indicated amounts of
N-protein (first through ninth lanes). Also
shown is the preformed complex treated
with RNase before (tenth lane) and after
(eleventh lane) UV cross-linking. The com-
plexes were resolved using 6% native gel.
Shifted bands are indicated by arrows. B,
shown is the biological activity of the I-
EDANS-labeled N-protein. Lane 1, leader
RNA; lane 2, leader RNA  N-protein;
lane 3, leader RNA  I-EDANS-labeled
N-protein. 2.5 M N-protein or I-EDANS-
labeled N-protein (see “Experimental Pro-
cedures”) was incubated with radiola-
beled leader RNA, and the complex was
resolved on 6% native polyacrylamide gel.
The gel was dried and autoradiographed.
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anisotropy is a function of rotational tumbling of the whole
molecule. Rapid internal motions, typical of partially or fully
disordered states, reduce the anisotropy values. An increase in
order generally should increase the fluorescence anisotropy
value of a probe covalently attached to the protein. Sulfhydryl
groups are selective attachment points for fluorescent probes.
The DTNB reaction was used for determining the number of
titrable sulfhydryl groups. 2.99  0.1 groups reacted with
DTNB, indicating that these sulfhydryl groups are available for
attachment of covalent probes. 2.93 0.19 I-EDANS molecules
were incorporated into the protein using the protocol described
under “Experimental Procedures.” This I-EDANS-labeled N-
protein showed full biological activity with respect to RNA-
binding ability as shown in Fig. 3B.
Table I reports the steady-state fluorescence anisotropy val-
ues of the I-EDANS-labeled soluble recombinant N-protein in
the presence and absence of the osmolyte D-sorbitol. The ani-
sotropy value in the absence of D-sorbitol is very low compared
with the expected value for a typical globular protein of 48 kDa.
For example, when attached to the -repressor dimer (molecu-
lar mass of 52 kDa), a dansyl chloride probe gave an anisotropy
value of 0.1 and a rotational correlation time of 20 ns under
similar conditions (12). We measured the lifetimes of the at-
tached I-EDANS probe in the presence and absence of D-sorbi-
tol. The lifetimes were 15.1 and 15.3 ns in the absence and
presence of D-sorbitol, respectively. If one calculates the rota-
tional correlation time from the Perrin equation assuming a
limiting anisotropy value of 0.4, the values are 0.8 and 2.2 ns
without and with D-sorbitol, respectively. These rotational cor-
relation times clearly indicate that there are very significant
internal motions indicative of disorder. The addition of D-sor-
bitol led to a significant increase in the fluorescence anisotropy
and rotational correlation time, indicating that the addition of
osmolytes leads to a decrease in internal motions. This is con-
sistent with the modest enhancement of the CD spectrum in
the presence of osmolytes.
Self-aggregation of the N-protein—The spectroscopic studies
reported above indicate that the soluble N-protein is partially
denatured and disordered. It is generally believed that such
partially denatured and disordered proteins are often prone to
aggregation. To investigate the self-aggregating tendency of
the soluble recombinant N-protein, dynamic light scattering
measurements were performed. For this experiment, Triton
X-100 was removed, and aggregation was monitored using
dynamic light scattering. DLS studies showed that the CHPV
N-protein formed large aggregates and that the change in
aggregate size occurred with time. While monitoring the aggre-
gation process of the N-protein, it was seen that 15 min after
the removal of Triton X-100, the protein started to form aggre-
gates (seen from the increasing value of the Stokes radius). Fig.
5A shows the DLS results after 60 min, when the protein
formed particles with an average Stokes radius of 8.8 nm (a
monomer of the size of the N-protein should have a Stokes
radius of 2–3 nm). After 18 h, it reached the saturation of the
aggregation process and formed particles with an average
Stokes radius of 16.05 nm (Fig. 5B). The standard error of these
measurements was 5% based on three independent measure-
ments. Clearly, the soluble N-protein has a tendency to aggre-
gate, which is reduced in the presence of nonionic detergents
such as Triton X-100.
Fluorescence anisotropy indicated that the osmolyte D-sorbi-
tol increased the local order in the N-protein. The reduction of
disorder, even a local one, may have an influence on the solu-
bility and aggregation of proteins. So we investigated the roles
of osmolytes present in the cells in solubilization of the N-
protein; and for this purpose, static light scattering experi-
ments were performed. The static light scattering technique is
widely used to study protein aggregation and disaggregation
(13). Aggregation of proteins gives rise to high light scattering
values, which reduce upon disaggregation. In this experiment,
first Triton X-100 was removed from a very high concentration
TABLE I
Steady-state fluorescence anisotropy of the I-EDANS-labeled N protein
in the presence and absence of osmolytes
A concentrated stock of the soluble recombinant N-protein was la-
beled with I-EDANS and diluted with 50 mM Tris-HCl (pH 8) containing
100 mM NaCl in the fluorometer cuvette to a final concentration of 0.5
M. The fluorescence anisotropy of this protein sample was measured in
the presence and absence of 250 mM D-sorbitol.
D-Sorbitol conc Fluorescenceanisotropy values
0 0.02
250 mM 0.05
FIG. 5. A, distribution of particle size measured by DLS 60 min after
removal of Triton X-100 from the soluble recombinant N-protein. Dy-
namic light scattering analysis was done using the Triton X-100-re-
moved soluble recombinant N-protein at 1 mg/ml. B, distribution of
particle size measured by DLS 18 h after removal of Triton X-100.
Dynamic light scattering analysis was done using the Triton X-100-
removed soluble recombinant N-protein at 1 mg/ml. The hydrodynamic
radius was calculated using Stokes-Einstein’s equation. All data were
collected taking an average of 100 scans, and the experiments were
done in 50 mM Tris-HCl (pH 8) containing 100 mM NaCl.
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of soluble recombinant N-protein using Bio-Beads SM-2 ad-
sorbent. The protein was then diluted to a final concentration
of 50 M in a fluorometer cuvette, and scattering values were
monitored as a function of time. This same experiment was
repeated, but D-sorbitol (250 mM) was included in the buffer
during detergent removal and light scattering measurements.
Table II reports the light scattering intensities after 30 min of
50 M N-protein in the presence and absence of osmolytes. The
light scattering value was reduced by severalfold in the pres-
ence of osmolytes. Clearly, the presence of 250 mM D-sorbitol
inhibited aggregation, suggesting that even an increase in the
local order leads to inhibition of self-aggregation of the
N-protein.
Chaperone-like Activity of the P-protein—As seen from the
above experiments, the N-protein is prone to aggregation,
which is partially alleviated in the presence of biological con-
centrations of osmolytes. We have explored other factors that
may influence the aggregation of the nascent N-protein. The
general machinery of chaperones may certainly influence the
outcome. Recent reports have suggested that the P-protein
forms a stable complex with the N-protein (14). We have thus
explored whether the P-protein can act as a chaperone for the
newly synthesized N-protein. During refolding at high dena-
turant concentrations, many proteins form large aggregates of
partially folded proteins. Many chaperones are known to sup-
press this kind of aggregation, which can be used as an assay
for chaperone activity. Light scattering is widely used to study
protein associations at equilibrium, and the scattering inten-
sity is proportional to the weight-average molecular weight of
the protein. Thus, aggregation gives rise to a high light scat-
tering value that is reduced in the presence of many chaper-
ones. For the purpose of this study, first the highly concen-
trated stock of the soluble N-protein was treated with Bio-
Beads SM-2 adsorbent to remove Triton X-100. After removal
of the detergent, the protein was denatured with 8 M urea and
was allowed to refold by diluting in a native buffer in the
fluorometer cuvette. Aggregation during refolding was moni-
tored by light scattering intensity. The scattering values as a
function of time were relatively flat, but much higher than
those of the protein-alone controls. This suggests that refolding
and aggregation were over within the mixing dead time. The
light scattering intensities at 10 min are presented in Table III
for different combinations of the P- and N-proteins.
As evident from Table III, in the presence of the P-protein,
the relative scattering intensities of the N-protein decreased
significantly, indicating that the CHPV P-protein can act like a
chaperone and can inhibit the aggregation of the N-protein. To
further substantiate the static light scattering data, DLS ex-
periments were performed. Aggregation of the N-protein in the
presence of the P-protein was monitored using dynamic light
scattering. 100 M N-protein was mixed with 100 M P-protein;
Triton X-100 in the protein mixture was removed using Bio-
Beads; and aggregation was monitored. As seen previously, in
the absence of the P-protein, the N-protein started to aggregate
after removal of the detergent within 15 min; and after 100
scans (after 60 min), the Stokes radius reached 8.8 nm. How-
ever, in the presence of the P-protein, there was no such in-
crease in the Stokes radius of the particles (data not shown).
Thus, the P-protein hinders the aggregation of the N-protein,
supporting the static light scattering data.
To determine if the CHPV P-protein is a generalized chap-
erone or is specific for the N-protein only, we measured
whether the CHPV P-protein can prevent the dithiothreitol-
induced aggregation of insulin. We found that the P-protein (10
M) had no influence on the dithiothreitol-induced aggregation
of insulin (data not shown). These two findings suggest that the
chaperone-like activity of the P-protein may be specifically
directed toward the N-protein or related proteins. In a recent
report, it has been suggested that osmolytes and chaperones
may act in a synergistic manner to refold proteins (15). We
have thus attempted to determine whether the P-protein and
D-sorbitol act in a synergistic manner. Table IV shows the
results of suppression of N-protein aggregation by D-sorbitol
and the P-protein as measured by static light scattering.
Clearly, the addition of the P-protein to D-sorbitol further en-
hanced aggregation suppression, over and above that achieved
by the osmolyte alone. Thus, the presence of the osmolyte
D-sorbitol lowers the concentration requirement of the P-pro-
tein for chaperone-like action.
If the P-protein exerts chaperone-like activity toward the
N-protein specifically, it is possible that a specific structural
determinant of the N-protein is recognized and not a general
hydrophobic interaction. This structural determinant must be
formed in the partially folded intermediates that are prone to
aggregation. Thus, we have tried to detect specific N-protein/
P-protein interaction. One of the best ways to study protein/
protein interaction is through use of fluorescence. We used the
I-EDANS-labeled CHPV N-protein as a probe and titrated it
with increasing concentrations of unlabeled bacterially ex-
pressed recombinant P-protein. Fig. 6 shows the fluorescence
enhancement as a function of increasing concentrations of P-
protein. The enhancement saturated quickly, suggesting a spe-
cific complex formation. The fluorescence increase can be fitted
to a binding equation with a dissociation constant of (1.19 
0.33)  106 M. From the previous discussion, it is quite clear
that the CHPV N-protein can self-aggregate and that the
CHPV P-protein can inhibit this aggregation process, and so
TABLE II
Aggregation of Triton X-100-C removed soluble recombinant N-protein
in the presence and absence of osmolytes using static light scattering
A concentrated stock of the soluble recombinant N-protein was taken
and from it was removed Triton X-100 using Bio-Beads SM-2 adsorbent.
Then, the protein stock was diluted with 50 mM Tris-HCl (pH 8) con-
taining 100 mM NaCl to a final concentration of 50 M. Static light
scattering intensity was monitored at 340 nm and excited at the same
wavelength as a function of time. The same experiment was repeated,
but 250 mM D-sorbitol was added during the detergent removal. All
values were corrected for the appropriate blank buffer value, and they
represent the scattering intensities after 30 min.
Conditions Scatteringintensities
50 M CHPV N-protein 876.97
50 M CHPV N-protein  250 mM D-sorbitol 259.3
TABLE III
Aggregation during refolding of urea-denatured N-protein in the
absence and presence of varying concentrations of P-protein monitored
by static light scattering
A concentrated stock of the soluble recombinant N-protein (N) was
taken, and from it was removed Triton X-100 using Bio-Beads SM-2
adsorbent. After removal of the detergent, the protein was denatured
with 8 M urea. This denatured stock was diluted with 50 mM Tris-HCl
(pH 8) containing 100 mM NaCl to a final concentration of 2 M in the
fluorometer cuvette, and aggregation during refolding was monitored
by light scattering intensity in the absence and presence of varying
concentrations of P-protein (P) (1, 2, 4, and 8 M). The values presented
were corrected for their appropriate buffer values containing respective
amounts of P-protein. Excitation and emission wavelengths were set at
340 nm.
Conditions Relative scatteringintensities
2 M N 803.91
2 M N  1 M P 479.41
2 M N  2 M P 234.61
2 M N  4 M P 199.41
2 M N  8 M P 190.61
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can D-sorbitol. We have previously seen that D-sorbitol induced
some local order, which may have some influence on the bind-
ing isotherm. Fig. 6 also shows the fluorescence increase in the
presence of 250 mM D-sorbitol. It is clear that the N- and
P-proteins interact in the presence of the osmolyte. The data
can be fitted to a dissociation constant of (0.8  0.37)  106 M.
DISCUSSION
In this study, we report for the first time the full-length
cloning of the Chandipura virus N gene. To fulfill the require-
ment of a large amount of N-protein for a detailed structure-
function analysis, it has been previously overexpressed both in
prokaryotic and eukaryotic systems. Expression of the N-pro-
tein alone in COS cells (16) as well as in bacteria (17) resulted
in formation of large insoluble aggregates, creating obstacles
for biological studies. However, in the VSV system, bacterial
coexpression of the P-protein along with the N-protein im-
proves its solubility (18). Here we have successfully overex-
pressed the N-protein in bacteria by changing induction pa-
rameters, resulting in the production of a soluble monomeric
form, which facilitated its characterization. We have developed
a single-step rapid purification procedure for this viral product
using a Mono-Q column. The N-protein encapsidates the nas-
cent genomic RNA during viral replication. The biological ac-
tivity of the soluble recombinant nucleocapsid protein is dem-
onstrated by its ability to bind viral RNA sequences and
enwrapping the leader RNA in an RNase-resistant form. En-
capsidation even at very low concentrations of N-protein indi-
cates that the recombinant protein is highly efficient in its
RNA-binding ability.
A disordered and free protein may be prone to aggregation.
This is also the case with the N-protein. However, what hap-
pens in vitro may be offset by some other factors in vivo, as in
the case of protein folding. We have identified two very impor-
tant factors that help prevent aggregation and solubilize the
N-protein, thus maintaining a pool of active N-protein for viral
packaging. The principal biological activity of the N-protein is
to package the viral genomic RNA. For packaging of a large
number of progeny viral genomes, a steady supply of N-pro-
teins is required during the life cycle of the virus. The self-
aggregation tendency of the free N-protein is of considerable
importance for the study of the protein. It is, however, unlikely
that self-aggregation is a property involved in the biological
role of the protein. It is, however, not unlikely that the disorder
of the isolated N-protein is because of its dissociation from the
viral genomic RNA. Many DNA-binding proteins are known
that are disordered in the free state and may have evolved that
way as a requirement for binding to multiple target sites (19).
It is possible that such a requirement is also present in the
N-protein.
The role of osmolytes in driving protein toward the native
state is now well established. This happens because, in partic-
ular, the peptide backbones have very unfavorable free ener-
gies for transfer from water to osmolyte solutions. Thus, they
favor any state that hides the peptide backbone from external
solvent, including the native state. The effect of osmolytes on
the aggregated state is not well known. It is generally believed
that aggregation occurs through partially folded states of pro-
teins. Although, in principle, osmolytes should favor native
states and thus reduce aggregation, the process is complicated
by the fact that aggregation also leads to removal of exposed
surface area through protein/protein interaction. It is possible
that osmolyte action on aggregation is more complex and re-
quires detailed study. In this study, we have shown that os-
molytes are capable of driving the N-protein toward a more
structured state that is soluble and less prone to aggregation.
Clearly, at least in this case, osmolytes have a beneficial effect
by disrupting the protein aggregation. Although we do not have
any direct in vivo data concerning the role of osmolytes in the
viral life cycle, given the widespread occurrence of intracellular
osmolytes, it is likely that the tendency of aggregation of the
N-protein will at least be partially offset by intracellular
osmolytes.
The role of the P-protein in the viral life cycle is well estab-
FIG. 6. Fluorescence enhancement of the I-EDANS-labeled N-
protein as a function of increasing concentrations of P-protein.
E, relative fluorescence values in the presence of D-sorbitol; , relative
fluorescence values in the absence of D-sorbitol. 0.5 M I-EDANS-la-
beled soluble recombinant N-protein was titrated with varying concen-
trations of phosphoprotein P (0–2 M), and the changes in relative
fluorescence intensity were monitored at 37 °C. All values were cor-
rected for the buffer values; and in the case of the presence of the
P-protein, the values were corrected for the contribution of correspond-
ing amounts of P-protein. These titrations were carried out in the
presence and absence of 250 mM D-sorbitol in 50 mM Tris-HCl (pH 8)
containing 100 mM NaCl. Each point is an average of three independent
measurements.
TABLE IV
Aggregation during refolding of urea-denatured N-protein in the
absence and presence of varying concentrations of P-protein and
D-sorbitol monitored by static light scattering
A concentrated stock of the soluble recombinant N-protein was taken,
and from it was removed Triton X-100 using Bio-Beads SM-2 adsorbent.
After removal of the detergent, the protein was denatured with 8 M
urea. This denatured stock was diluted with 50 mM Tris-HCl (pH 8)
containing 100 mM NaCl to a final concentration of 1 M in the fluo-
rometer cuvette, and aggregation during refolding was monitored by
light scattering intensity in the absence and presence of varying con-
centrations of D-sorbitol and in the presence of 0.25 M each P-protein
and D-sorbitol. Excitation and emission wavelengths were set at 340
nm.
Conditions Scatteringintensities
1 M N 471
1 M N  125 mM D-sorbitol 324.6
1 M N  250 mM D-sorbitol 248.9
1 M N  500 mM D-sorbitol 250.2
1 M N  0.25 M P 374.6
1 M N  125 mM D-sorbitol  0.25 M P 274
1 M N  250 mM D-sorbitol  0.25 M P 261.8
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lished. In its phosphorylated form, the protein is a transcrip-
tion activator. We have established another important role of
the P-protein in the functioning of the N-protein. The recom-
binant P-protein interacts with the N-protein, with dissociation
constants in the low micromolar range. This affinity is crucial
for interaction with the N-protein and prevents aggregation.
The P-protein has a highly negatively charged N-terminal do-
main, which is a characteristic of many chaperones. It has been
hypothesized that the negatively charged regions keep the
protein complexes soluble, preventing aggregation (20).
A recent report has indicated that osmolytes and chaperones
together can be used to refold proteins (in this case, a mutant)
that are otherwise difficult to refold. Based on the experiments
reported here, we suggest that the cooperation of an osmolyte
and a chaperone in refolding a protein may have a much wider
occurrence in vivo and may be a widely applicable in vitro tool
for the refolding of proteins.
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